SSG
AMED

Summit Securities Group’s Amedisys AMED Stock Holding History

Summit Securities Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100,000
Closed -$9.84M – 1007
2025
Q2 		$9.84M Buy
+100,000
New +$9.46M 1.89% 9
2025
Q1 		– Sell
-40,000
Closed -$3.63M – 777
2024
Q4 		$3.63M Buy
+40,000
New +$3.67M 0.75% 32

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Summit Securities Group's AMED Position: Q4 2024 in Review

Summit Securities Group sold out of Amedisys (AMED) in Q4 2024, closing a stake of 65 shares — an estimated $5.97K sold.

Summit Securities Group first reported a position in AMED in Q3 2023 and held it in 4 quarters. The position peaked at $1.25M in Q3 2023. 290 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

  • Summit Securities Group reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
  • Summit Securities Group sold 65 Amedisys shares in Q4 2024, an estimated $5.97K.
  • Summit Securities Group first reported a position in Amedisys in Q3 2023 and held it in 4 quarters.
  • Summit Securities Group's Amedisys position peaked at $1.25M in Q3 2023.
  • 290 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on Summit Securities Group's 13F filing for Q4 2024, filed 12 Feb 2025.